RecruitingNCT05641441

Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma


Sponsor

University Hospital, Geneva

Enrollment

258 participants

Start Date

Jan 24, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The investigators aim to study the impact of stereotactic radiosurgery, for the treatment of vestibular Schwannoma, on the cochlear, vestibular, gustatory, and facial nerve functions and compare it with a conservatively treated group. The predictive value of radiological tumor characteristics on hearing preservation and vestibular function will be also evaluated. Additionally, the investigators will invite patients with vestibular Schwannoma to fill out questionnaires to assess their quality of life.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Stereotactic radiosurgery for people with ototoxicity and vestibular schwannoma. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONStereotactic radiosurgery

Stereotactic radiosurgery


Locations(1)

Service d'ORL et Chirurge cervico-faciale, Hopitaux Universitaires de Genève

Geneva, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05641441


Related Trials